30Dec 2024
CCL3 Enhances NEC Diagnosis in Neonates

CCL3 Enhances NEC Diagnosis in Neonates

A study evaluated the diagnostic value of serum CCL3 levels for neonatal necrotizing enterocolitis (NEC), comparing it with commonly used biomarkers like procalcitonin (PCT) and C-reactive protein (CRP). CCL3 demonstrated a higher diagnostic accuracy with an area under the curve (AUC) of 0.8614, sensitivity of 83.33%, and a negative predictive value of 80.55%. Combined use of CCL3 and PCT significantly enhanced diagnostic performance (AUC=0.903).

  • #pediatrics

Like

Save

Share